| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |